Potential Therapeutic Target for Alzheimer's Identified

by VR Sreeraman on  July 30, 2009 at 1:50 PM Research News
RSS Email Print This Page Comment
 Potential Therapeutic Target for Alzheimer's Identified
Scientists at Bristol University have made an important discovery, which could help in the treatment of Alzheimer's disease.
Advertisement

The researchers have found the enzyme called endothelin converting enzyme-2 (ECE-2), may cause the blood flow in the brain to drop and therefore cause the disease to worsen.

Advertisement
"Our findings raise the possibility that drugs that can block the actions of endothelin-1 and which are already licensed for treating other diseases, may also be of benefit for the treatment of Alzheimer's disease," said Jennifer Palmer from the university's Dementia Research Group.

In a normal brain, blood flow responds to nerve cell activity. If this activity increases, so does the supply of blood that is needed to meet the extra demand for nutrients such as glucose and oxygen.

If this demand is not met, as can happen in Alzheimer's disease, the nerve cells may not function normally and may eventually die.

The study has been published in the July issue of the American Journal of Pathology.

Source: ANI
LIN
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Creutzfeldt-Jakob Disease Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive